- Home
- SMTI vs JGH Comparison
SMTI vs JGH Comparison
Compare SMTI & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- JGH
- Stock Information
- Founded
- SMTI 1982
- JGH 2014
- Country
- SMTI United States
- JGH United States
- Employees
- SMTI N/A
- JGH N/A
- Industry
- SMTI Medical/Dental Instruments
- JGH Investment Managers
- Sector
- SMTI Health Care
- JGH Finance
- Exchange
- SMTI Nasdaq
- JGH Nasdaq
- Market Cap
- SMTI 288.2M
- JGH 308.3M
- IPO Year
- SMTI N/A
- JGH N/A
- Fundamental
- Price
- SMTI $36.64
- JGH $13.36
- Analyst Decision
- SMTI Buy
- JGH
- Analyst Count
- SMTI 1
- JGH 0
- Target Price
- SMTI $44.00
- JGH N/A
- AVG Volume (30 Days)
- SMTI 35.0K
- JGH 73.9K
- Earning Date
- SMTI 11-12-2024
- JGH 01-01-0001
- Dividend Yield
- SMTI N/A
- JGH 9.85%
- EPS Growth
- SMTI N/A
- JGH N/A
- EPS
- SMTI N/A
- JGH N/A
- Revenue
- SMTI $78,056,873.00
- JGH N/A
- Revenue This Year
- SMTI $29.95
- JGH N/A
- Revenue Next Year
- SMTI $19.68
- JGH N/A
- P/E Ratio
- SMTI N/A
- JGH N/A
- Revenue Growth
- SMTI 24.66
- JGH N/A
- 52 Week Low
- SMTI $26.00
- JGH $10.36
- 52 Week High
- SMTI $43.25
- JGH $12.85
- Technical
- Relative Strength Index (RSI)
- SMTI 56.60
- JGH 65.09
- Support Level
- SMTI $34.50
- JGH $13.23
- Resistance Level
- SMTI $37.60
- JGH $13.36
- Average True Range (ATR)
- SMTI 1.88
- JGH 0.09
- MACD
- SMTI -0.23
- JGH 0.03
- Stochastic Oscillator
- SMTI 59.81
- JGH 100.00
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.